• E-mail
  • Save
32 Stories on Rheumatoid Arthritis
Search this topic

What do you know about new MS treatment?

I am an MS [multiple sclerosis] patient and I have just about had it with my Rebif injections. I've heard about a new leukemia drug used to treat the beginning stages of MS. I think it's called Campath 1H. Are there any other medications you would recommend for early stage MS? Thank you.

Fortune: Analyst face-off: Abbott Labs

Shares of Abbott Laboratories stabilized Tuesday after dropping more than 2% in the previous session when it said it would buy the industry's biggest Lasik vision equipment maker for $2.8 billion.

CNNMoney: Schering stock jumps on job cuts

Schering-Plough's stock jumped Thursday, after the drugmaker's chief executive announced he would cut 10% of its staff.

CNNMoney: Amgen earnings, sales beat forecast

Biotech Amgen on Thursday reported an increase in earnings and a decrease in sales for the fourth quarter, beating Wall Street's forecast.

CNNMoney: Abbott's quarterly results top estimates

Abbott Laboratories, a maker of drugs and medical devices, reported on Wednesday a jump in sales and earnings that beat Wall Street's estimates.

CNNMoney: Amgen earnings meet forecasts

The biotech Amgen reported first-quarter earnings Monday that matched expectations, though its revenue fell just short of forecasts.

CNNMoney: Abbott pitches Humira for psoriasis

Abbott Laboratories is trying to get its top-selling blockbuster drug approved for yet another use, which could lead to further sales.

CNNMoney: Amgen reports surge in earnings, sales

A surge in Amgen Inc's fourth-quarter earnings fell short of analyst projections, but the company's sales topped expectations.

CNNMoney: The making of Gardasil

On the site of a former amusement park in a small Pennsylvania town, technicians sheathed in plastic suits labor over stainless steel fermentation tanks that look like brewery vats.

CNNMoney: Pfizer, Lilly, Wyeth beat forecasts

Big Pharma companies Pfizer, Lilly and Wyeth beat analysts' expectations Thursday with reports of strong gains in third-quarter earnings, though Pfizer isn't expecting annual profit growth until 2009 and is ramping up its already ambitious cost-cutting efforts.

Advertisement
Quick Job Search :
keyword(s):
enter city: